Urgent Health Insurance Prior Authorization Denial: Forcing a 72-Hour Expedited Appeal¶

Receiving a health insurance prior authorization denial ("Adverse Benefit Determination") 24 to 72 hours before a scheduled cancer surgery, chemotherapy infusion, radiation cycle, cardiac procedure, spine operation, or life-critical specialty medication is a terrifying medical and legal emergency. Health insurers and Pharmacy Benefit Managers (PBMs) increasingly use automated Utilization Management (UM) algorithms (such as Evicore, AIM Specialty Health / Carelon, Cohere Health, or NaviHealth) to batch-reject complex procedures as "Not Medically Necessary," "Experimental / Investigational," or subject to "Step Therapy (Fail-First)" rules, often reviewed in seconds by a nurse or an out-of-specialty physician who has never treated your condition. Do not cancel your treatment or pay tens of thousands of dollars out of pocket without first triggering your mandatory federal right to an Expedited 24-to-72-Hour Urgent Care Appeal. Under the federal Affordable Care Act (ACA, 42 U.S.C. Section 300gg-19), ERISA (29 CFR Section 2560.503-1), and Medicare Advantage / Part D rules (42 CFR Parts 422 and 423), whenever waiting for a standard 30-day appeal would seriously jeopardize your life, health, or ability to regain maximum function, or subject you to severe pain, you and your treating physician have the statutory right to force (1) a mandatory Expedited Internal Appeal decided within 72 hours (or 24 hours for urgent prescription drugs in many states), AND (2) a simultaneous Expedited External Review by an independent, board-certified specialist at an Independent Review Organization (IRO) whose decision is 100% legally binding on the insurance company. If your medical condition deteriorates into an acute life-threatening medical emergency while waiting for authorization, go to the nearest hospital Emergency Department or call your local emergency numbers immediately; under the federal Emergency Medical Treatment and Labor Act (EMTALA) and the No Surprises Act, emergency room stabilization can never require prior authorization. For related health and billing emergencies, see Medical bill collections, hospital financial aid, and charity care, Short-term, long-term, and ERISA disability insurance claim denial and appeal, and COBRA subsidy lapse, special enrollment deadline, and retroactive Medicaid.

Do this now¶

1. Go to the Emergency Department immediately if you have acute life-threatening symptoms. If you experience chest pain, shortness of breath, stroke symptoms, uncontrolled bleeding, high fever (38.5 degrees Celsius / 101.3 degrees Fahrenheit or higher during chemotherapy neutropenia), or acute organ distress, call your local emergency numbers (911 in the US and Canada, 112 in the EU, 999 in the UK, 000 in Australia) or go to the nearest hospital Emergency Department. Under the federal No Surprises Act (42 U.S.C. Section 300gg-111) and ACA (29 CFR Section 2590.715-2719A), health plans are strictly prohibited by federal law from requiring Prior Authorization for emergency services, even at an out-of-network hospital.
2. Have your treating physician call the insurer's Medical Director for an immediate "Peer-to-Peer (P2P) Physician Review" before the short P2P window closes. Third-party utilization reviewers (like Evicore or Carelon) typically allow your doctor only 2 to 5 business days after an initial denial to conduct a Peer-to-Peer (P2P) telephone call before locking the file into the formal appeals department. Ask your surgeon's or oncologist's Prior Authorization Coordinator today to schedule an urgent P2P call, and insist that the insurer provide a true clinical peer (a physician board-certified in the same or similar specialty who typically manages the condition, such as a board-certified medical oncologist reviewing a chemotherapy regimen, rather than a retired general practitioner or obstetrician).
3. Demand the Complete "Claim File," Internal Clinical Coverage Criteria (InterQual / Milliman Care Guidelines), and the Name, NPI Number, and Board Specialty of the Denying Doctor. Under federal ERISA (29 CFR Section 2560.503-1(h)(2)(iii)) and ACA regulations (45 CFR Section 147.136), the insurer must provide you, free of charge, with:
4. The exact internal clinical rule, guideline, or protocol (such as McKesson InterQual, Milliman Care Guidelines / MCG, or internal PBM policy bulletin) relied upon to deny your procedure;
5. A written explanation of the scientific or clinical judgment for any "Not Medically Necessary" or "Experimental/Investigational" denial; and
6. The full name, medical license number, National Provider Identifier (NPI), and board certification specialty of the physician or reviewer who signed the denial.
7. File a "72-Hour Expedited Urgent Care Internal Appeal" AND a "Simultaneous Expedited External Review (IRO)" today. Do not let your doctor's office submit a "Standard Pre-Service Appeal" (which gives the insurer 30 calendar days to review your file). Under 29 CFR Section 2560.503-1(i)(2)(i) and 45 CFR Section 147.136(b)(2)(ii)(B), if your treating physician states that waiting for a standard timeframe could (a) seriously jeopardize your life or health, (b) jeopardize your ability to regain maximum function, OR © subject you to severe pain that cannot be adequately managed without the requested care or treatment, the insurer MUST accept the request orally or by fax and issue a binding decision within 72 hours (or less). Furthermore, federal law allows you to request an Expedited External Independent Review (IRO) at the exact same time as your Expedited Internal Appeal.
8. If the insurer denies an urgent prescription drug or chemotherapy agent due to "Step Therapy / Fail-First" or "Non-Formulary" status, trigger a "24-Hour Urgent Exception Request." Under Medicare Part D (42 CFR Section 423.568), ACA Essential Health Benefits rules (45 CFR Section 156.122©), and state Step-Therapy Override statutes in over 38 U.S. states, health plans must grant an Expedited Formulary / Step-Therapy Exception within 24 hours when the prescribing doctor certifies that the insurer's preferred alternative drug is contraindicated, likely to be ineffective based on your genetic/biomarker profile, or likely to cause an adverse reaction.
9. Never sign an "Advance Beneficiary Notice of Noncoverage (ABN)" or "Financial Waiver" agreeing to pay cash before exhausting your 72-hour expedited review. Once the procedure is already performed and paid for, your appeal shifts from an Urgent Pre-Service Claim (72-hour deadline) to a Post-Service Reimbursement Claim (where the insurer has 60 days and you lose urgent leverage). Force the 72-hour pre-service expedited review first whenever clinically safe.

Decision tree: Forcing an expedited 24-to-72-hour prior authorization reversal¶

flowchart TD
    A["Prior Authorization Denied for Urgent Surgery, Cancer Care, Imaging, or Specialty Drug"] --> B{"1. Is the patient experiencing an acute emergency right now?"}
    B -->|"Yes: Acute Emergency"| C["Go to Emergency Department Immediately: EMTALA & No Surprises Act (42 U.S.C. 300gg-111) Strictly Prohibit Prior Auth for Emergency Stabilization"]
    B -->|"No: Scheduled Urgent Procedure / Drug Within Days"| D["Step 1 (Within 24 Hours): Treating Doctor Demands Urgent 'Peer-to-Peer (P2P)' Call With a Board-Certified Same-Specialty Medical Director"]
    D --> E{"Did the Peer-to-Peer (P2P) Call Overturn the Denial?"}
    E -->|"Yes: Approved"| F["Get Written Authorization Reference Number & Confirm Coding (CPT / J-Code) Matches Hospital / Infusion Center Order"]
    E -->|"No (or Insurer Refuses Same-Specialty Peer)"| G["Step 2 (Simultaneous Filing): Treating Doctor Certifies 'Urgent Care Claim' Under 29 CFR 2560.503-1(m)(1)(ii) to Trigger Mandatory 72-Hour Expedited Internal Appeal (24 Hours for Urgent Rx)"]
    G --> H["Step 3 (File Simultaneously, Do Not Wait): File 'Simultaneous Expedited External Review' With Independent Review Organization (IRO) Under 45 CFR 147.136(d)(2)(ii)"]
    H --> I["Step 4: Demand Denying Reviewer's Name, NPI, & Specialty + Copy State Insurance Commissioner / EBSA & Manufacturer Bridge Program (for Specialty Drugs)"]

Phase 1: Know your exact statutory clock (24 hours vs. 72 hours) by plan type¶

Every health insurance plan in the United States falls into one of four legal frameworks, each with strict federal or state statutory countdown clocks for Urgent / Expedited Prior Authorization Appeals:

Phase 2: Exposing the "Out-of-Specialty Reviewer" and "AI Algorithm" denial¶

Investigative reports by ProPublica, the U.S. Senate Permanent Subcommittee on Investigations, and state insurance regulators have revealed that insurers use automated algorithms to reject hundreds of thousands of claims in seconds, signed off by company doctors who are not board-certified in the relevant medical specialty (for example, a pediatrician or family practitioner denying a complex neurosurgical procedure or Stage IV oncology proton beam therapy).

1. Your Federal Right to a "Same-or-Similar Specialty" Clinical Reviewer on Appeal¶

While insurers often use a non-specialist for the initial denial, federal law makes it illegal for the insurer to use the same reviewer or an unqualified reviewer when you file your Expedited Appeal:

• Mandatory Different, Unsubordinated Reviewer (29 CFR Section 2560.503-1(h)(3)(ii)): On appeal, the review cannot be conducted by the individual who made the initial denial or by any subordinate of that individual, and must give zero deference to the initial denial.
• Mandatory Consultation with a Appropriately Trained and Experienced Specialist (29 CFR Section 2560.503-1(h)(3)(iii)): In deciding any appeal of a denial that is based in whole or in part on a medical judgment (including whether a treatment, drug, or scan is "medically necessary" or "experimental / investigational"), the health plan MUST consult with a health care professional who has appropriate training and experience in the field of medicine involved in the medical judgment.
• Mandatory Disclosure of Every Expert Consulted (29 CFR Section 2560.503-1(h)(3)(iv)): The plan must identify by name and credentials every medical or vocational expert whose advice was obtained on behalf of the plan, whether or not the advice was relied upon.

2. How to Use the "Specialty Mismatch" to Force an Instant Reversal¶

In your Expedited Appeal packet (and during your doctor's Peer-to-Peer call), look up the denying physician's name on the ABMS (American Board of Medical Specialties) CertificationMatters.org database and the CMS NPI Registry (npiregistry.cms.hhs.gov):

• If a radiation oncology plan or immunotherapy infusion was denied by an internal medicine doctor, an OB/GYN, or an orthopedic surgeon, state in bold at the top of your appeal:
• "NOTICE OF PROCEDURAL VIOLATION UNDER 29 CFR Section 2560.503-1(h)(3)(iii): The initial adverse determination was signed by Dr. [Name], NPI #[Number], who is board-certified in [Unrelated Specialty] and holds zero board certification or subspecialty fellowship training in [Relevant Specialty, e.g., Medical Oncology / Neurosurgery]. Pursuant to federal law and applicable state utilization review statutes, we demand that this 72-Hour Expedited Appeal be reviewed solely by an actively practicing physician who is board-certified in [Exact Specialty] and that their full name, NPI, and board certification be disclosed in writing."

Phase 3: How to beat the 4 most common Prior Authorization denial reasons¶

When writing your 72-hour Expedited Appeal and Physician Letter of Medical Necessity, match your evidence to the exact boilerplate code on the insurer's denial letter:

1. Denial Reason: "Not Medically Necessary" (Beating InterQual / MCG Guidelines)¶

• Why it happens: Insurers license commercial checklists (InterQual or Milliman Care Guidelines / MCG) that require rigid checkboxes (for example, "6 weeks of conservative physical therapy before spine MRI/surgery").
• How to beat it: First, demand a copy of the exact InterQual/MCG page the insurer used (they must give it to you free under 29 CFR Section 2560.503-1). Second, have your doctor show either (a) that your chart actually meets every InterQual/MCG bullet point (often the hospital faxed incomplete chart notes missing the physical therapy dates), OR (b) that under CMS rules (42 CFR Section 422.101©) and national specialty society guidelines (such as NCCN Guidelines for cancer, ACC/AHA for cardiology, or NASS for spine), commercial InterQual screening tools cannot override consensus peer-reviewed clinical guidelines when a patient has "red-flag" neurological deficits or rapid tumor progression.

2. Denial Reason: "Experimental or Investigational" (Especially for Cancer, PET Scans, Proton Therapy, or Off-Label Drugs)¶

• Why it happens: Insurers label modern treatments (like PSMA PET scans, proton beam radiation, genomic tumor profiling, or targeted immunotherapies) "Experimental/Investigational" because the insurer's internal policy manual has not been updated since 2021.
• How to beat it:
• For Cancer Care (NCCN Category 1 or 2A Mandate): Cite the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Under federal Medicare rules, ACA rules, and state cancer-coverage mandates across the majority of states, any regimen, biomarker test, or off-label indication listed as Category 1 or Category 2A in the NCCN Drugs & Biologics Compendium (or supported in Micromedex / AHFS-DI / Clinical Pharmacology) is legally recognized as standard-of-care and NOT experimental. Attach the exact NCCN Guideline page showing Category 1 or 2A status.
• Trigger Simultaneous External IRO Review Immediately: Insurers lose over 50% to 70% of "Experimental/Investigational" denials when elevated to an external Independent Review Organization (IRO) because the IRO assigns a practicing academic specialist who follows current peer-reviewed literature rather than the insurer's outdated internal cost-cutting policy.

3. Denial Reason: "Step Therapy / Fail-First Required" (For Biologics, Chemotherapy, Autoimmune, or Specialty Drugs)¶

• Why it happens: The insurer's PBM demands that you "try and fail" two cheap generic drugs for 90 days before they will pay for the biologic or targeted drug your specialist prescribed.
• How to beat it (24-Hour Step-Therapy Override): Under state Step-Therapy Override laws (enacted in over 38 states, including California, New York, Texas, Florida, Illinois, and Ohio) and federal ACA / Medicare Part D rules, the insurer MUST grant an override within 24 to 72 hours if your doctor certifies any one of these 5 statutory exceptions:
• The required step-therapy drug is contraindicated or will likely cause an adverse reaction or physical/mental harm to the patient;
• The required step-therapy drug is expected to be ineffective based on the known clinical characteristics of the patient (such as genetic/biomarker mutation testing) and the known characteristics of the drug regimen;
• The patient already tried and failed the required drug (or another drug in the same pharmacological class) under a previous health insurance plan (you do not have to fail the same drug twice just because you switched insurers);
• The required drug is not in the best interest of the patient based on medical necessity because it will create a barrier to adherence or worsen a comorbid condition; or
• The patient is already stable on the prescribed drug (Continuity of Care).

4. Denial Reason: "Out-of-Network Provider / Facility" (For Rare Cancers or Specialized Surgery)¶

• How to beat it ("Network Gap Exception / Single-Case Agreement"): If your insurer's local HMO/PPO network does not have an in-network surgeon or center of excellence with the specific subspecialty expertise to perform your complex surgery within a reasonable travel distance and timeframe, file an urgent Network Adequacy Gap Exception ("In-Network Exception for Out-of-Network Provider"). Under the ACA and state network adequacy laws, when a health plan lacks an available, qualified in-network specialist, the plan must execute a Single-Case Agreement (SCA) covering the out-of-network specialist at in-network cost-sharing rates.

Phase 4: Verbatim "72-Hour Expedited Internal & Simultaneous External Appeal" demand template¶

Fax this notice (keep the fax confirmation sheet) AND upload it through the insurer's portal today, together with your treating physician's signed Urgent Certification & Letter of Medical Necessity:

URGENT: 72-HOUR EXPEDITED INTERNAL APPEAL AND SIMULTANEOUS EXPEDITED EXTERNAL REVIEW (IRO)
SUBMITTED PURSUANT TO 29 CFR Section 2560.503-1(i)(2)(i), 45 CFR Section 147.136, AND 42 U.S.C. Section 300gg-19

Date & Exact Time of Transmission: [Insert Date and Time, e.g., October 31, 2026 at 10:15 AM EST]
VIA EXPEDITED APPEALS FAX ([Insert Insurer Urgent Appeals Fax #]) AND PORTAL UPLOAD

To: Expedited Utilization Management / Urgent Appeals Department & Medical Director
[Name of Health Insurance Company / Third-Party Administrator / PBM]

Patient Name: [Full Name] | Date of Birth: [DOB] | Member ID #: [ID Number] | Group #: [Group Number]
Denial Reference / Claim #: [Insert Reference Number] | Date of Denial: [Date]
Ordering Physician: [Doctor Name, MD, Specialty, NPI #, Direct Phone & Fax #]
Scheduled Procedure / Drug & CPT/HCPCS/J-Code: [Insert Exact Procedure/Drug Name & Codes]
Scheduled Date of Procedure / Infusion: [Insert Date]

1. MANDATORY 72-HOUR EXPEDITED URGENT CARE APPEAL TRIGGER (24 HOURS FOR URGENT RX):
Please take formal notice that the patient's treating physician, [Dr. Name], a physician with clinical knowledge of the patient's condition, has certified that this is an URGENT CARE CLAIM within the meaning of 29 CFR Section 2560.503-1(m)(1)(ii) and 45 CFR Section 147.136 because applying the standard non-urgent pre-service timeframe would: (a) seriously jeopardize the patient's life or physical health, (b) jeopardize the patient's ability to regain maximum function, and/or (c) subject the patient to severe pain that cannot be adequately managed without the requested care or treatment.
Under 29 CFR Section 2560.503-1(m)(1)(ii), the determination of the patient's attending physician that a claim involves urgent care is CONCLUSIVE and legally binding upon the Plan. You are required by federal law to issue a written determination as soon as possible, and NO LATER THAN SEVENTY-TWO (72) HOURS from this transmission (or 24 hours for an urgent prescription drug exception under 45 CFR Section 156.122(c) / 42 CFR Section 423.572).

2. DEMAND FOR SIMULTANEOUS EXPEDITED EXTERNAL REVIEW BY AN IRO (45 CFR Section 147.136(d)(2)(ii)):
Pursuant to 29 CFR Section 2590.715-2719(d) and 45 CFR Section 147.136(d)(2)(ii)(B), we hereby simultaneously request an EXPEDITED EXTERNAL REVIEW by an accredited Independent Review Organization (IRO). Under federal law, a claimant with an urgent care claim is entitled to request an expedited external IRO review at the exact same time as an expedited internal appeal, and is deemed to have exhausted internal appeals if the Plan fails to strictly adhere to all federal urgent claims requirements.

3. DEMAND FOR SAME-SPECIALTY BOARD-CERTIFIED REVIEWER & DISCLOSURE OF CREDENTIALS:
Pursuant to 29 CFR Section 2560.503-1(h)(3)(ii)-(iv), this appeal may not be reviewed by the initial reviewer or their subordinate, and MUST be reviewed in consultation with a physician who holds active board certification and clinical training in [Insert Exact Medical Specialty, e.g., Medical Oncology / Neurological Surgery]. We demand immediate disclosure of:
(a) The full name, NPI number, state license number, and board certification specialty of both the initial denying reviewer and the appellate reviewer; and
(b) A complete copy of the internal clinical criteria, InterQual/MCG guideline, or medical policy relied upon.

4. SUMMARY OF CLINICAL MEDICAL NECESSITY (SEE ATTACHED PHYSICIAN LETTER & RECORDS):
[Dr. Name]'s attached Letter of Medical Necessity, pathology/imaging reports, and peer-reviewed guidelines ([e.g., NCCN Category 1 / 2A Guidelines]) establish that [Requested Procedure/Drug] is medically necessary standard-of-care treatment for the patient's diagnosis ([ICD-10 Code]).

Please transmit your expedited approval within the mandatory statutory deadline to [Dr. Name] at Fax #[Doctor Fax] and to the patient at [Phone/Email].

Sincerely,

[Patient or Authorized Representative Signature & Printed Name]
[Treating Physician Signature & Printed Name, MD, NPI #]

Enclosures: Treating Physician Certification of Urgency & Letter of Medical Necessity; Clinical Chart Notes & Imaging/Pathology Reports; Peer-Reviewed Specialty Guidelines (NCCN / Specialty Society).
cc: U.S. Department of Labor - Employee Benefits Security Administration (EBSA) [for ERISA Plans]
    [State Department of Insurance / Department of Managed Health Care - Urgent Consumer Help Unit]
    [CMS Medicare Ombudsman - for Medicare Advantage / Part D Plans]

Regional emergency numbers and agency protocols¶

For any acute medical emergency, call your local emergency numbers immediately. To force regulatory intervention on an urgent health insurance prior authorization denial:

• United States:
• Self-Funded Employer Plans (ERISA): Call the U.S. Department of Labor - Employee Benefits Security Administration (EBSA) Benefits Advisors at 1-866-444-3272 (askebsa.dol.gov). EBSA Benefits Advisors can contact your employer's plan administrator directly when a plan violates the 72-hour urgent appeal rule.
• State-Regulated Commercial & ACA Marketplace Plans: Call your State Department of Insurance (DOI) Urgent Consumer Assistance Program (in California, call the Department of Managed Health Care (DMHC) Help Center 24/7 Urgent Line at 1-888-466-2219, HealthHelp.ca.gov; in New York, call the DFS External Appeal Line at 1-800-400-8882).
• Medicare Advantage (Part C) & Medicare Part D: Call 1-800-MEDICARE (1-800-633-4227) (24/7) to file an Expedited Appeal & Complaint, or contact your state SHIP and the Medicare Rights Center (medicarerights.org, 1-800-333-4114).
• Free Patient Advocacy Legal Help: Contact the Patient Advocate Foundation (PAF) (patientadvocate.org or 1-800-532-5274) or Triage Cancer (triagecancer.org).
• Canada:
• Provincial Public Health Coverage (OHIP / MSP / RAMQ / AHCIP): File an Expedited Appeal with the provincial review board (such as Ontario's Health Services Appeal and Review Board - HSARB) and apply to the drug manufacturer's Compassionate Access Program.
• Private Workplace Extended Health / Drug Plans: Escalate urgent specialty drug denials to the OmbudService for Life and Health Insurance (OLHI) (olhi.ca or 1-888-295-8112).
• United Kingdom:
• NHS England / Integrated Care Boards (ICBs): Your consultant can submit an Urgent Individual Funding Request (IFR) (processed within 24 to 48 hours for clinically urgent life-or-limb-threatening cases) and contact PALS (nhs.uk).
• Private Medical Insurance (Bupa / AXA / Aviva / Vitality): Escalate immediately to the Financial Ombudsman Service (FOS) (financial-ombudsman.org.uk or 0800 023 4567).
• European Union:
• Cross-Border Urgent Healthcare (EU Regulation 883/2004 & Directive 2011/24/EU): Under the European Court of Justice's Watts and Elchinov rulings, a national statutory health insurer cannot refuse prior authorization (Form S2) for hospital treatment in another EU Member State if medically necessary treatment cannot be provided domestically within a medically justifiable time limit.
• Australia and New Zealand:
• Australia (Private Health Insurance): Under the Private Health Insurance Act 2007, private hospital insurers cannot refuse cover for a clinical category covered by your policy tier once waiting periods are served. Escalate urgent disputes to the Commonwealth Ombudsman (Private Health Insurance Ombudsman) at ombudsman.gov.au (1300 362 072), or New Zealand's IFSO (ifso.nz, 0800 888 202).

Frequently asked questions¶

What if the hospital threatens to cancel my surgery tomorrow morning because my insurance company is still "reviewing" the prior authorization?¶

First, have your surgeon's office call the insurer's Urgent Appeals / Medical Director line and formally state that this is an Urgent Care Claim under 29 CFR Section 2560.503-1(m)(1)(ii). Second, ask the hospital's Financial Counseling / Utilization Review Director to hold your operating-room slot while the 24-to-72-hour expedited review completes, OR, if your condition has become acutely unstable, ask your surgeon whether admitting you through the Emergency Department is clinically indicated (because Emergency Stabilization services under the federal No Surprises Act and EMTALA cannot be denied for lack of prior authorization). Third, call your State Department of Insurance Urgent Help Line (or DOL EBSA at 1-866-444-3272 for self-funded employer plans) today, as regulators have direct escalation contacts inside every major insurer's medical director office.

How do I know whether my employer's health plan is a "Self-Funded ERISA Plan" or a "State-Regulated Fully Insured Plan"?¶

Look at your insurance ID card or ask your HR department: "Is our medical plan self-funded by the employer under ERISA, or is it fully insured through a state-regulated policy?" (On many ID cards, a fully insured plan prints the letters "DOI" or "CDI / DMHC / TDI / DFS" in the bottom corner, whereas a self-funded ERISA plan says "Administered by [Insurer] / ASO"). Either way, both self-funded ERISA plans and state-regulated ACA plans are bound by the federal 72-Hour Expedited Internal Appeal rule and the Simultaneous Expedited External IRO Review rule under 29 CFR Section 2590.715-2719.

What is an "Independent Review Organization (IRO)," and how often do patients win an External Review?¶

An Independent Review Organization (IRO) is an accredited, third-party panel of practicing, board-certified medical specialists completely independent of your health insurance company. When you trigger an Expedited External Review, your medical records are sent electronically to an IRO physician who is board-certified in the exact specialty treating your condition. The IRO must issue its decision within 72 hours in an urgent case. Across state and federal external review databases, patients overturn insurance denials in 40% to 65%+ of cases (and over 70% in specialized cancer and rare-disease cases). Under federal law, if the IRO rules in your favor, the insurance company is 100% legally required to pay for the treatment immediately, and the external review costs you $0.

Can I get a 72-hour emergency supply of my medication at the pharmacy counter if my insurance denies prior authorization on a Friday night?¶

For Medicaid patients: YES, mandatory by federal law. Under 42 U.S.C. Section 1396r-8(d)(5)(B), every Medicaid program and Medicaid Managed Care plan must provide at least a 72-hour emergency supply of a covered outpatient prescription drug whenever prior authorization is unavailable. For Medicare Part D patients: Under 42 CFR Section 423.120(b)(3), plans must provide a one-time 30-day temporary "Transition Fill" during the first 90 days of a plan year or after a level-of-care change while an exception is pending. For Commercial Plans: Many states mandate 72-hour to 5-day emergency pharmacy overrides, and your pharmacist can also call the PBM's 24/7 Pharmacy Help Desk for an Emergency Override Code.

What if my insurer approved the prior authorization BEFORE my surgery, and then denies payment AFTER the surgery was performed?¶

Under Retroactive Denial Prohibition Statutes enacted in over 40 U.S. states (and under federal No Surprises Act / ERISA promissory estoppel rules), once a health insurer issues a written Prior Authorization Approval for a specific procedure and CPT code, the insurer is statutorily barred from retroactively revoking that authorization or denying the claim for "lack of medical necessity" after the doctor has already performed the surgery in reliance on the approval, unless the insurer proves intentional fraud or that your policy terminated before the date of service.

Related guides¶

• Medical bill collections, hospital financial aid, and charity care
• Short-term, long-term, and ERISA disability insurance claim denial and appeal
• COBRA subsidy lapse, special enrollment deadline, and retroactive Medicaid
• Loss of health insurance
• Medical malpractice, never events, hospital record preservation, and patient advocate
• Emergency numbers by country

Sources and official guidance¶

• U.S. Department of Labor - Employee Benefits Security Administration (EBSA) (United States): ERISA Claims Procedure Regulations (29 CFR Section 2560.503-1: Urgent Care 72-Hour Deadlines, Conclusive Physician Determination of Urgency under Section 2560.503-1(m)(1)(ii), and Same-Specialty Consultation under Section 2560.503-1(h)(3)(iii)) and ACA Internal and External Review Rules (29 CFR Section 2590.715-2719).
• U.S. Department of Health and Human Services (HHS) & CMS (United States): 45 CFR Section 147.136 (ACA Expedited Internal and Simultaneous External IRO Review); 45 CFR Section 156.122© (24-Hour Urgent Prescription Drug Exception); 42 CFR Sections 422.572, 422.590, 423.572, and 423.590 (Medicare Advantage & Part D Expedited Determinations); and 42 U.S.C. Section 1396r-8(d)(5) (Medicaid 24-Hour Prior Auth & 72-Hour Emergency Drug Supply).
• No Surprises Act & EMTALA (United States): 42 U.S.C. Section 300gg-111 & 29 CFR Section 2590.715-2719A (Ban on Prior Authorization for Emergency Medical Services).
• HealthCare.gov, Patient Advocate Foundation, & International Ombudsmen: How to Appeal a Health Insurance Decision (healthcare.gov/appeal-insurance-company-decision); NHS England Individual Funding Request (IFR) Policy; and Australian Private Health Insurance Ombudsman (ombudsman.gov.au).